Structure |
Chemical Name |
CAS |
MF |
|
Crisaborole Impurity 14 |
|
|
|
Benzonitrile, 4-[(1E)-4-(dimethylamino)-1-(4-fluorophenyl)-1-buten-1-yl]-3-(hydroxymethyl)- |
1370643-23-4 |
C20H21FN2O |
|
Latamoxef impurity B |
|
|
|
(9alpha,13alpha,14alpha)-3-methoxymorphinan-17-carbaldehyde |
28973-48-0 |
C18H23NO2 |
|
(R)-De(trifluoromethyl) Fluoxetine Hydrochloride |
1212215-97-8 |
C16H20ClNO |
|
(1R,5S)-1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one |
96847-52-8 |
C11H10O2 |
|
(1R,1'R,2S,2'S)-2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-Isoquinolinium Benzenesulfonate |
96946-46-2 |
C59H77N2O15S+ |
|
(2R,3R,4R,5R)-2-(4-amino-2-oxo-1,3,5-triazin-1(2H)-yl)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-3-yl acetate |
|
C10H14N4O6 |
|
12-ethyl-8-methyl-9-oxo-7-propionyl-9,11-dihydroindolizino[1,2-b]quinolin-2-yl [1,4'-bipiperidine]-1'-carboxylate |
176515-52-9 |
C32H38N4O4 |
|
4-amino-5-chloro-N-(1-propylpiperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
|
C17H24ClN3O2 |
|
Ceftazidime Impurity D |
|
|
|
Ceftazidime Sulfoxide Impurity |
|
|
|
Tofacitinib Impurity Y |
|
|
|
5-amino-6-chloro-2-(propylthio)pyrimidin-4-ol |
|
C7H10ClN3OS |
|
Labetalol EP impurity G |
|
|
|
2-(2-NITROPHENYL)ETHANAMINE |
33100-15-1 |
C8H10N2O2 |
|
CLOZAPINE-D3 |
1215691-72-7 |
C18H19ClN4 |
|
Bumetanide iMpurity F |
|
|
|
IODIXANOL RELATED COMPOUND D (50 MG) (5-[ACETYL(2-HYDROXY-3-METHYLPROPYL)AMINO]-N,N'-BIS(2,3-DIHYDROXYPROPYL)2,4,6-TRIIODO-1,3-BENZE-NEDICARBOXAMIDE) |
89797-00-2 |
C20H28I3N3O9 |
|
NIMODIPINE RELATED COMPOUND B (50 MG) (BIS(2-METHOXYETHYL) 2,6-DIMETHYL-4-(3-NITROPHE-NYL)-1,4-DIHYDROPYRIDINE-3,5-DICARBOXYLATE) (AS) |
70172-96-2 |
C21H26N2O8 |
|
1-METHYL-2-PHENOXYETHYLAMINE |
35205-54-0 |
C9H13NO |
|
SULPIRIDE IMPURITY B |
|
|
|
3-(7,8-dimethoxy-2-oxo-1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)-N-(((S)-3,4-dimethoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)methyl)-N-methylpropan-1-amine oxide |
2511244-97-4 |
C27H36N2O6 |
|
2,4,6,3',5'-pentamethoxybiphenyl |
84212-55-5 |
C17H20O5 |
|
Labetalol EP Impurity I |
|
|
|
(Asp4)-Carbetocin (Impurity G) |
|
|
|
Sulfamide, N-[5-(4-bromophenyl)-6-[2-[(5-chloro-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propyl- |
2443747-63-3 |
C19H20BrClN6O4S |
|
methyl 3-oxo1,2-benzisothiazole-2(3H)-acetate 1,1-dioxide |
6639-62-9 |
C10H9NO5S |
|
(6R-cis)-3-(hydroxymethyl)-7-methoxy-8-oxo-7-(2-thienylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
54333-94-7 |
C15H16N2O6S2 |
|
5-acetyl-1,3-phenylene bis(dimethylcarbamate) |
81732-48-1 |
C14H18N2O5 |
|
Oseltamivir Impurity L |
|
|
|
1,4-Naphthalenediol, 2-methyl-, 4-acetate |
110327-29-2 |
C13H12O3 |
|
Oseltamivir Impurity 105 |
|
|
|
Oseltamivir Impurity 77 |
|
|
|
Imidapril Impurity 2 |
|
|
|
Betamethasone EP Impurity G |
85700-75-0 |
C22H30O5 |
|
Crisaborole Impurity ABCDEFGHJKL |
|
|
|
3-Azetidinecarboxylic acid, 1-[(4-acetyl-2-ethylphenyl)methyl]- |
2474774-17-7 |
C15H19NO3 |
|
Benazepril Related Compound F |
|
|
|
2-(N,N-DIETHYLAMINO)-4,6-DICHLOROTRIAZINE |
2401-64-1 |
C5H6Cl2N4 |
|
(S)-4-Chloro-1,3-butanediol |
139013-68-6 |
C4H9ClO2 |
|
6-CHLORO-1-METHYLURACIL |
31737-09-4 |
C5H5ClN2O2 |
|
5-(Propylthio)-1H-benzimidazol-2-amine |
80983-36-4 |
C10H13N3S |
|
Ethyl 4,5-bis(2-methoxyethoxy)-2-nitrobenzoate |
179688-26-7 |
C15H21NO8 |
|
Hexyl methanesulfonate |
16156-50-6 |
C7H16O3S |
|
5-CHLOROTHIOPHENE-3-CARBOXYLIC ACID |
36157-42-3 |
C5H3ClO2S |
|
(S)-(+)-1-[(4-Chlorophenyl)phenylmethyl]piperazine |
439858-21-6 |
C17H19ClN2 |
|
2,8-Dichloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-β]pyridin-11-one |
133330-61-7 |
C14H9Cl2NO |
|
2-Isopropyl-6-propylphenol (Propofol Impurity O) |
74663-48-2 |
C12H18O |
|
3-Methyl-2-(3,4-dimethoxyphenyl)butyronitrile |
20850-49-1 |
C13H17NO2 |
|
HYDROXY ITRACONAZOLE |
112559-91-8 |
C35H38Cl2N8O5 |
|
1-HEXADECANOYL-2-(P-NITROPHENOXYSUCCINOYL)-SN-GLYCERYL-3-PHOSPHORYLCHOLINE |
170569-87-6 |
C16H12F3N3O2S |
|
N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide |
1038972-16-5 |
C13H18N4O3 |
|
1,4-BIS[3,4-DIHYDRO-2(1H)-QUINOLINON-7-OXY]BUTANE |
882880-12-8 |
C22H24N2O4 |
|
2,3'-Bipyridine, 5-chloro-3-[4-(methylsulfonyl)phenyl]-, hydrochloride (1:1) |
202409-39-0 |
C17H14Cl2N2O2S |
|
1,1'-((methylenebis(4-methoxy-3,1-phenylene))bis(2-(dimethylamino)ethane-1,1-diyl))dicyclohexanol |
|
|
|
2-amino-4-(2-(benzyl(1-(4-methoxyphenyl)propan-2-yl)amino)-1-hydroxyethyl)phenol |
|
|
|
Peramivir Deacetyl Impurity |
|
|
|
Empagliflozin Impurity 116 |
|
|
|
(3R,5aS)-5,8-dioxooctahydro-5H-pyrrolo[1,2-a]thiazolo[3,2-d]pyrazine-3-carboxylic acid |
|
|
|
Phospholipid Impurity 1(DPPE-MPEG5000 Impurity 1) |
|
|
|
Carbazochrome Sodium Sulfonate Impurity 4 |
|
|
|
Empagliflozin Furanose Impurity |
|
|
|
Rosuvastatin Impurity 144 |
|
|
|
Cetrorelix Impurity 11 |
|
|
|
Cetrorelix Impurity 4 (8-D-Arg) |
|
|
|
Cetrorelix Impurity 1 (+L-Arg) |
|
|
|
Peramivir Intermediate Impurity 36 |
|
|
|
Peramivir Intermediate Impurity 41 |
|
|
|
Peramivir Impurity 999 |
|
|
|
Palonosetron impurity 20XH |
|
|
|
Apixaban Impurity 89 |
|
|
|
Levofloxacin benzopazine impurity |
|
|
|
Bumetanide Impurity 14 |
1431501-10-8 |
C21H27NO3 |
|
Trans,rel-(1R,4R)-4-{[(2-Aminophenyl)methyl]amino}cyclohexan-1-ol Hydrochloride |
|
|
|
Sugammadex Sodium Impurity 08 |
|
|
|
2-bromo-3-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)benzonitrile |
|
|
|
INDEX NAME NOT YET ASSIGNED |
2412953-12-7 |
C72H112O49S8 |
|
4a(2H)-Isoquinolinol, octahydro-4-(4-methoxyphenyl)-2-methyl- |
2568340-30-5 |
C17H25NO2 |
|
3-Quinolinecarbonitrile, 4-[(2,4-dichloro-5-hydroxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]- |
2468737-92-8 |
C25H27Cl2N5O3 |
|
Uridine, 4-oxime, 5'-(2-methylpropanoate), (4E)- |
2492423-30-8 |
C13H19N3O7 |
|
Empagliflozin Furanose Impurity |
|
|
|
Tazobactam Impurity XTE |
|
|
|
1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-, (2S-trans)- |
111188-70-6 |
C22H26N2O4S |
|
1H-Benzimidazole-2-sulfinicacid(9CI) |
58536-71-3 |
C7H6N2O2S |
|
1(3H)-Isobenzofuranone,3-methyl-(9CI) |
3453-64-3 |
C9H8O2 |
|
3-ETHOXY-4-METHOXYBENZOIC ACID |
2651-55-0 |
C10H12O4 |
|
4-hydroxyurapidil |
88733-12-4 |
C20H29N5O4 |
|
2-chloro-4-nitrophenyl-N-acetylglucosaminide |
103614-82-0 |
C14H17ClN2O8 |
|
desisopropylprocaterol |
63483-95-4 |
C13H16N2O3 |
|
10-bromocarbamazepine |
59690-97-0 |
C15H11BrN2O |
|
ethyl apovincaminate |
42971-12-0 |
C22H26N2O2 |
|
ALS 8123 |
81148-15-4 |
C15H23NO4 |
|
Ro 14-7437 |
78756-03-3 |
C15H15N3O3 |
|
4-(2-Cyanophenyl)benzaldehyde |
135689-93-9 |
C14H9NO |
|
(R)-SN-38 |
647852-82-2 |
C22H20N2O5 |
|
5'-Deoxy-5-fluoro-N4-(isopentyloxycarbonyl)cytidine |
162204-30-0 |
C15H22FN3O6 |
|
4-[(2,3-Dihydro-5,6-dimethoxy-1H-inden-2-yl)methyl]-1-(phenylmethyl)piperidine Hydrochloride |
1034439-57-0 |
C24H32ClNO2 |
|
5-(aminosulfonyl)-2-methoxybenzamide |
52395-25-2 |
C8H10N2O4S |
|
PIPERIDINE-3-CARBOXYLIC ACID (2,6-DIMETHYL-PHENYL)-AMIDE |
337488-90-1 |
C14H20N2O |